Tenivac Suspension For Injection 2-5Lf Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

TENIVAC: Suspension for injection (2-5Lf)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

DIPHTHERIA AND TETANUS TOXOIDS ADSORBED (dif THEER ee uh and TET n us TOK soids ad SAWRB) is a vaccine. It is used to prevent infections of diphtheria and tetanus (lockjaw).

In-Depth Information

TENIVAC Suspension for Injection

NDC: 492810215
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Tetanus Prophylaxis, Diphtheria Prophylaxis

Storage Information
Refrigerate (between 36 and 46 degrees F)
Discard product if it contains particulate matter, is cloudy, or discolored
Do not freeze
Discard product if exposed to freezing
TENIVAC Suspension for Injection

Reported Side Effects for TENIVAC Suspension for Injection

Injection Site Reaction Incidence:
<80.1%*
Severity: MILD
Onset: RAPID
Skin Redness Incidence:
<25.6%*
Severity: MODERATE
Onset: EARLY
Breathing Difficulties Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Anaphylactoid Reactions Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Guillain-Barre Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Angioedema Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Fever Incidence:
0.7-6.6%*
Severity: MILD
Onset: EARLY
Weakness Incidence:
4.9-32.3%*
Severity: MILD
Onset: EARLY
Joint Pain Incidence:
7.4-15.7%*
Severity: MILD
Onset: DELAYED
Feeling Sick Incidence:
8.8-17.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
10.8-25.1%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with TENIVAC

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5